Literature DB >> 29479261

Overweight and obesity are associated with lower vitamin D status in Canadian children and adolescents.

Linda S Greene-Finestone1, Didier Garriguet2, Stephen Brooks3, Kellie Langlois2, Susan J Whiting4.   

Abstract

INTRODUCTION: There is evidence that 25-hydroxyvitamin D levels are lower in overweight and obese youth. This study examined the relationship between weight status and 25-hydroxyvitamin D, while controlling for confounders, in Canadian youth.
METHODS: Plasma 25-hydroxyvitamin D from subjects aged 6 to 17 years from the Canadian Health Measures Survey cycles 1 (2007 to 2009) and 2 (2009 to 2011) was used. Sex-specific multiple linear regression and logistic regressions examined the relationship of overweight and obesity (body mass index ≥ 85th percentile) with 25-hydroxyvitamin D levels and the odds of 25-hydroxyvitamin D <40 nmol/L and <50 nmol/L.
RESULTS: The prevalence of risk of vitamin D deficiency (25-hydroxyvitamin D < 30 nmol/L) was 6% (95% confidence interval [CI] 3.26% to 10.12%). Vitamin D inadequacy, estimated by levels <40 nmol/L, was 15% (95% CI 10.34% to 20.39%; 19% [95% CI 13.1 to 25.6] for teenagers). Seventy per cent (95% CI 63.59 to 75.17) had levels >50 nmol/L, consistent with achieving the Recommended Dietary Allowance. In adjusted analyses, overweight/obesity (1/3 of subjects) was independently associated with lower 25-hydroxyvitamin D for both sexes after adjustment for age, race, income, season, vitamin D supplementation and daily milk consumption. For 25-hydroxyvitamin D <40 nmol/L, the overweight/obese odds ratio for males was 2.63 (95% CI 1.34 to 5.18). For 25-hydroxyvitamin D <50 nmol/L, overweight/obese odds ratios were 2.19 (95% CI 1.46 to 3.28) for males and 1.39 (95% CI 1.05 to 1.84) for females.
CONCLUSIONS: This study confirms the inverse association between adiposity and serum concentrations of 25-hydroxyvitamin D in Canadian youth and the independent association of overweight/obesity to 25-hydroxyvitamin D level and vitamin D status after adjustment for other factors.

Entities:  

Keywords:  25-Hydroxyvitamin D; Adolescents; Canadian Health Measures Survey; Children; Obesity; Overweight; Vitamin D

Year:  2017        PMID: 29479261      PMCID: PMC5804960          DOI: 10.1093/pch/pxx116

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  27 in total

1.  Calculated ultraviolet exposure levels for a healthy vitamin D status.

Authors:  Ann R Webb; Ola Engelsen
Journal:  Photochem Photobiol       Date:  2006 Nov-Dec       Impact factor: 3.421

Review 2.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

3.  Canadian Health Measures Survey: sampling strategy overview.

Authors:  Suzelle Giroux
Journal:  Health Rep       Date:  2007       Impact factor: 4.796

4.  Canadian Health Measures Survey: rationale, background and overview.

Authors:  Mark Tremblay; Michael Wolfson; Sarah Connor Gorber
Journal:  Health Rep       Date:  2007       Impact factor: 4.796

5.  Low vitamin D status among obese adolescents: prevalence and response to treatment.

Authors:  Zeev Harel; Patricia Flanagan; Michelle Forcier; Dalia Harel
Journal:  J Adolesc Health       Date:  2011-05       Impact factor: 5.012

6.  Decreased bioavailability of vitamin D in obesity.

Authors:  J Wortsman; L Y Matsuoka; T C Chen; Z Lu; M F Holick
Journal:  Am J Clin Nutr       Date:  2000-09       Impact factor: 7.045

7.  Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females.

Authors:  Ambika P Ashraf; Jessica A Alvarez; Barbara A Gower; Karen H Saenz; Kenneth L McCormick
Journal:  Obesity (Silver Spring)       Date:  2011-05-05       Impact factor: 5.002

8.  Canadians' eating habits.

Authors:  Didier Garriguet
Journal:  Health Rep       Date:  2007-05       Impact factor: 4.796

9.  Relationship between serum 25-hydroxyvitamin D concentration and risks of metabolic syndrome in children and adolescents from Korean National Health and Nutrition Examination survey 2008-2010.

Authors:  Dong Yup Lee; Ah Reum Kwon; Jung Min Ahn; Ye Jin Kim; Hyun Wook Chae; Duk Hee Kim; Ho-Seong Kim
Journal:  Ann Pediatr Endocrinol Metab       Date:  2015-03-31

10.  Metabolic syndrome in canadian adults and adolescents: prevalence and associated dietary intake.

Authors:  Solmaz Setayeshgar; Susan J Whiting; Hassanali Vatanparast
Journal:  ISRN Obes       Date:  2012-11-20
View more
  6 in total

Review 1.  Vitamin D in physiological and pathological aging: Lesson from centenarians.

Authors:  Evelyn Ferri; Martina Casati; Matteo Cesari; Giovanni Vitale; Beatrice Arosio
Journal:  Rev Endocr Metab Disord       Date:  2019-09       Impact factor: 6.514

2.  Protective effect of nano vitamin D against fatty degeneration in submandibular and sublingual salivary glands: A histological and ultrastructural study.

Authors:  Rasha Hamed Al-Serwi; Mohamed El-Sherbiny; Mohamed Ahmed Eladl; Ashwag Aloyouny; Ishrat Rahman
Journal:  Heliyon       Date:  2021-04-29

3.  Association of Vitamin D Receptor Gene Polymorphisms with Metabolic Syndrome in Chinese Children.

Authors:  Di Wang; Kunkai Su; Zhongxiang Ding; Zhiqun Zhang; Chunlin Wang
Journal:  Int J Gen Med       Date:  2021-01-12

4.  Vitamin D in pediatric patients with obesity and arterial hypertension.

Authors:  Živa Radulović; Zarja Polak Zupan; Aljoša Tomazini; Nataša Marčun Varda
Journal:  Sci Rep       Date:  2021-10-01       Impact factor: 4.379

5.  Associations between Body Composition and Vitamin D Status in Children with Overweight and Obesity Participating in a 1-Year Lifestyle Intervention.

Authors:  Popi Kasvis; Tamara R Cohen; Sarah-Ève Loiselle; Tom J Hazell; Catherine A Vanstone; Hope A Weiler
Journal:  Nutrients       Date:  2022-07-30       Impact factor: 6.706

6.  Relationship between Vitamin D level and metabolic parameters in obese children and response to Vitamin D treatment.

Authors:  Dilek Damla Saymazlar; Ozlem Kara; Betul Biner Orhaner
Journal:  North Clin Istanb       Date:  2022-07-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.